{"id":"W1986010889","doi":"10.1111/ejh.12052","title":"Rash with the multitargeted kinase inhibitors nilotinib and dasatinib: meta‐analysis and clinical characterization","year":2012,"lang":"en","type":"review","venue":"European Journal Of Haematology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto","funders":"Canadian Dermatology Foundation; Dermatology Foundation; American Society of Hematology","keywords":"Nilotinib; Dasatinib; Medicine; Rash; Incidence (geometry); Internal medicine; Tyrosine-kinase inhibitor; Adverse effect; Dermatology; Myeloid leukemia; Imatinib; Cancer","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002200676,0.0004462042,0.004553707,0.0003957213,0.00008800389,0.0000298947,0.000169509,0.0001351601,0.0001039526],"category_scores_gemma":[0.0001912174,0.0002104277,0.001015513,0.0003809253,0.0003568336,0.00009755687,0.0001184146,0.0008683013,0.00002521319],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006037177,"about_ca_system_score_gemma":0.0002578594,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000002651948,"about_ca_topic_score_gemma":0.00000551621,"domain_scores_codex":[0.9946876,0.002898585,0.001556024,0.0003260632,0.0002563329,0.0002754544],"domain_scores_gemma":[0.9961351,0.0006818678,0.002308379,0.0003970995,0.0001626671,0.0003148705],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.0002458792,0.0004867246,0.005692035,0.00584242,0.3792394,0.01090297,0.0005021005,3.090645e-7,0.00000508341,0.00003113951,0.0002973618,0.5967546],"study_design_scores_gemma":[0.002071374,0.0005664185,0.003733698,0.0008814806,0.5439346,0.02045283,0.00003079768,0.000004848182,0.000001814783,3.506166e-7,0.428105,0.0002167859],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0134684,0.9851069,0.0001817623,0.0003856609,0.0001822398,0.0005321883,0.0000203058,0.00001559982,0.000106982],"genre_scores_gemma":[0.009281563,0.9888556,0.0009712556,0.0001539711,0.000406832,0.000005087724,0.0001023067,0.00009214986,0.0001312545],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.5965378,"threshold_uncertainty_score":0.8580992,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0988586204046646,"score_gpt":0.3572264443656417,"score_spread":0.2583678239609771,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}